|
US2021008172A1
|
|
Long-acting igf-1 or igf-1 variants and methods of producing same
|
|
WO2020165900A1
|
|
Long-acting glp-2 analogs
|
|
WO2019211842A1
|
|
Long-acting human growth hormone-antagonists and methods of producing the same
|
|
AU2017296352A1
|
|
Long-acting coagulation factor VII and methods of producing same
|
|
WO2017212494A1
|
|
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
|
US2018360932A1
|
|
Long-acting coagulation factors and methods of producing same
|
|
KR20180014754A
|
|
Pegylated oxine tomoldulin variant
|
|
CA2914916A1
|
|
Methods of producing ctp-modified growth hormone polypeptides
|
|
US2015258208A1
|
|
Pegylated OXM variants
|
|
IL238904D0
|
|
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
|
AU2015201906A1
|
|
Long-acting coagulation factors and methods of producing same
|
|
US2015141331A1
|
|
Long-acting polypeptides and methods of producing and administering same
|
|
US2015093358A1
|
|
Long-acting polypeptides and methods of producing and administering same
|
|
US2015148291A1
|
|
Long-acting polypeptides and methods of producing and administering same
|
|
AU2014338575A1
|
|
Long-acting polypeptides and methods of producing and administering same
|
|
IL234082D0
|
|
Long-acting coagulation factors and methods of producing same
|
|
US2015079063A1
|
|
Long-acting coagulation factors and methods of producing same
|
|
IL230757D0
|
|
Long-acting growth hormone and methods of producing same
|
|
PE20210171A1
|
|
METHOD TO INCREASE THE HYDRODYNAMIC VOLUME OF POLYPEPTIDES BY BINDING TO GONADOTROPHIN PEPTIDES OF EXTREME CARBOXI
|
|
US2015072924A1
|
|
Long-acting oxyntomodulin variants and methods of producing same
|
